MA did a nice job with interview. And the exposure cant hurt. Everything there known by longtermers. I did find this very interesting; " We are actively working with a partner on diabetes indication." That would be huge. I wonder who partner might be.?
I agree. No new "news" for long termers but a concise, informative, and potentially compelling interview for investors unaware of the company/EECP or for those investors in the past that bailed due to poor mgmt to take a fresh look at the company.
On the EECP side, we are working on the reimbursement-expansion strategy to improve our market penetration in the U.S. in the cardiology market. We also have some ongoing research that Vasomedical sponsored for other non-cardiac indications, hopefully to get FDA clearance in the future. One thing I should mention is diabetes. We have seen strong published evidence that the glucose level of diabetic patients, as well as the insulin resistance level of the prediabetic and diabetic patients, all improved after one course of EECP Therapy, so we are working actively with our partner in that area and we are in communication with the FDA to get a clear idea on how we can get these indications cleared. Once we have these indications, the EECP market size will increase significantly. I have to make a disclaimer here: The timeline for this to happen is not clear, and I am not in a position to make a prediction if and when it would happen. But, all I can actually say is that we are working on it and if we can get clearance, I think the market should be as large as the cardiology market, if not larger.
You are right partner "SOUR GRAPES" is what this giant human shaker producing. NOTHING but SOUR GRAPES.
Lets revise what the company did over the past 2yrs: The good Doctor said:
"Let me extend the time frame a bit longer: In the last 12 to 18 months we have accomplished a lot.
Actually, if I could extend it a little further, a little more than two years ago"
SInce the last pump about TWO YEARS when the pps went up to $0.745 and dropped about -400% I was able to get a RAISE and a BONUS and 500k of FREE shares. Nice. Well at least someone is making money.
The company has return on total asset (ROA) of 2.26 % which means that it generated profit of $2.26 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of 14.83 % meaning that it generated $14.83 on every $100 dollars invested by stockholders.
That excuse of a "Disgruntled Employee" selling shares... good one... lol
I just call it as I see it. Again, the market is in full on bull run, new highs, money flowinf in, but dear VASO is DEAD in the water. MONEY TALKS. NO hard feelings. :-)